# Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer

> **NCT07720115** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Phase II
- S-531011
- RadScopal
- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** S-531011
- **RADIATION:** HD-XRT

## Key facts

- **NCT ID:** NCT07720115
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-08-12
- **Primary completion:** 2026-09-04
- **Final completion:** 2026-09-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** 0 participants
- **Last updated:** 2026-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07720115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07720115, "Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07720115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*